{"transactions":[{"id":4629069,"issuer":{"id":1723,"kind":"organization","name":"Stoke Therapeutics, Inc.","symbol":"STOK"},"owners":[{"id":22216,"kind":"person","name":"Allan Jonathan","position":1,"cik":"0001966716","reported_name":"Allan Jonathan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"GENERAL COUNSEL & CORP SEC"}}],"security":"Common Stock","published_at":"2026-10-02T21:37:29.000Z","date":"2026-10-02","kind":"sale","planned":true,"acquired":false,"shares":627,"price":26.33,"value":16508.91,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 10, 2025."}],"balance_after":20598,"source":{"system":"sec-edgar","filing":"0001966716-26-000014","document":"form4-10022026_091025.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1966716/000196671626000014/form4-10022026_091025.xml","form_type":"4"}},{"id":4629074,"issuer":{"id":1723,"kind":"organization","name":"Stoke Therapeutics, Inc.","symbol":"STOK"},"owners":[{"id":1724,"kind":"person","name":"Ticho Barry","position":1,"cik":"0001780088","reported_name":"Ticho Barry","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF MEDICAL OFFICER"}}],"security":"Common Stock","published_at":"2026-10-02T21:35:56.000Z","date":"2026-10-01","kind":"sale","planned":true,"acquired":false,"shares":1051,"price":26.1594,"value":27493.5294,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 19, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $25.91 to $26.51 per share, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":19059,"source":{"system":"sec-edgar","filing":"0001780088-26-000023","document":"form4-10022026_091051.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1780088/000178008826000023/form4-10022026_091051.xml","form_type":"4"}},{"id":4626937,"issuer":{"id":1723,"kind":"organization","name":"Stoke Therapeutics, Inc.","symbol":"STOK"},"owners":[{"id":38786,"kind":"person","name":"Cumbo Alexander","position":1,"cik":"0001685994","reported_name":"Cumbo Alexander","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (Right to Buy)","published_at":"2026-09-25T20:12:39.000Z","date":"2026-09-23","kind":"grant","planned":false,"acquired":true,"shares":39674,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option award shall vest as to 1/12th of the total award quarterly on the 23rd calendar day of each December, March, June, and September, with the first tranche vesting on December 23, 2026, subject to the reporting person's continued service to the Issuer through each vesting date."}],"balance_after":39674,"derivative":{"exercise_price":26.11,"expiration_date":"2036-09-22","underlying":"Common Stock","underlying_shares":39674},"source":{"system":"sec-edgar","filing":"0001685994-26-000009","document":"form4-09252026_080935.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1685994/000168599426000009/form4-09252026_080935.xml","form_type":"4"}},{"id":2247,"issuer":{"id":1723,"kind":"organization","name":"Stoke Therapeutics, Inc.","symbol":"STOK"},"owners":[{"id":1724,"kind":"person","name":"Ticho Barry","position":1,"cik":"0001780088","reported_name":"Ticho Barry","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF MEDICAL OFFICER"}}],"security":"Common Stock","published_at":"2026-09-03T20:17:14.000Z","date":"2026-09-01","kind":"sale","planned":true,"acquired":false,"shares":1600,"price":31.0569,"value":49691.04,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 19, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $30.96 to $31.20 per share, inclusive."}],"balance_after":20110,"source":{"system":"sec-edgar","filing":"0001780088-26-000021","document":"form4-09032026_080910.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1780088/000178008826000021/form4-09032026_080910.xml","form_type":"4"}},{"id":2246,"issuer":{"id":1723,"kind":"organization","name":"Stoke Therapeutics, Inc.","symbol":"STOK"},"owners":[{"id":1724,"kind":"person","name":"Ticho Barry","position":1,"cik":"0001780088","reported_name":"Ticho Barry","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF MEDICAL OFFICER"}}],"security":"Common Stock","published_at":"2026-09-03T20:17:14.000Z","date":"2026-09-01","kind":"sale","planned":true,"acquired":false,"shares":3945,"price":30.512,"value":120369.84,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 19, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $29.94 to $30.92 per share, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote and in footnote 3 of this Form 4."}],"balance_after":21710,"source":{"system":"sec-edgar","filing":"0001780088-26-000021","document":"form4-09032026_080910.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1780088/000178008826000021/form4-09032026_080910.xml","form_type":"4"}},{"id":683638,"issuer":{"id":1723,"kind":"organization","name":"Stoke Therapeutics, Inc.","symbol":"STOK"},"owners":[{"id":1724,"kind":"person","name":"Ticho Barry","position":1,"cik":"0001780088","reported_name":"Ticho Barry","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF MEDICAL OFFICER"}}],"security":"Performance Stock Units","published_at":"2026-08-19T00:29:50.000Z","date":"2026-08-14","kind":"exercise","planned":false,"acquired":false,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"Each performance stock unit represents a right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Achievement of this performance stock unit award was certified on August 14, 2025.  Pursuant to the terms of the award agreement between the reporting person and the Issuer, half the award vested on August 14, 2025 and the remainder vests on August 14, 2026, subject to the reporting person's continued service to the Issuer on the relevant vesting date."}],"balance_after":0,"derivative":{"expiration_date":"2026-08-14","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001780088-26-000019","document":"form4-08192026_120845.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1780088/000178008826000019/form4-08192026_120845.xml","form_type":"4"}},{"id":683637,"issuer":{"id":1723,"kind":"organization","name":"Stoke Therapeutics, Inc.","symbol":"STOK"},"owners":[{"id":1724,"kind":"person","name":"Ticho Barry","position":1,"cik":"0001780088","reported_name":"Ticho Barry","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF MEDICAL OFFICER"}}],"security":"Common Stock","published_at":"2026-08-19T00:29:50.000Z","date":"2026-08-18","kind":"sale","planned":false,"acquired":false,"shares":242,"price":32.4681,"value":7857.2802,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transaction represents an Issuer mandated sale to satisfy tax withholding liabilities in connection with the vesting and settlement of restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $32.44 to $32.54 per share, inclusive."}],"balance_after":25655,"source":{"system":"sec-edgar","filing":"0001780088-26-000019","document":"form4-08192026_120845.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1780088/000178008826000019/form4-08192026_120845.xml","form_type":"4"}},{"id":683636,"issuer":{"id":1723,"kind":"organization","name":"Stoke Therapeutics, Inc.","symbol":"STOK"},"owners":[{"id":1724,"kind":"person","name":"Ticho Barry","position":1,"cik":"0001780088","reported_name":"Ticho Barry","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF MEDICAL OFFICER"}}],"security":"Common Stock","published_at":"2026-08-19T00:29:50.000Z","date":"2026-08-18","kind":"sale","planned":false,"acquired":false,"shares":4525,"price":32.0072,"value":144832.58,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transaction represents an Issuer mandated sale to satisfy tax withholding liabilities in connection with the vesting and settlement of restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $31.40 to $32.36 per share, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote and in footnote 3 of this Form 4."}],"balance_after":25897,"source":{"system":"sec-edgar","filing":"0001780088-26-000019","document":"form4-08192026_120845.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1780088/000178008826000019/form4-08192026_120845.xml","form_type":"4"}},{"id":683635,"issuer":{"id":1723,"kind":"organization","name":"Stoke Therapeutics, Inc.","symbol":"STOK"},"owners":[{"id":1724,"kind":"person","name":"Ticho Barry","position":1,"cik":"0001780088","reported_name":"Ticho Barry","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF MEDICAL OFFICER"}}],"security":"Common Stock","published_at":"2026-08-19T00:29:50.000Z","date":"2026-08-14","kind":"exercise","planned":false,"acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":30422,"source":{"system":"sec-edgar","filing":"0001780088-26-000019","document":"form4-08192026_120845.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1780088/000178008826000019/form4-08192026_120845.xml","form_type":"4"}},{"id":683470,"issuer":{"id":1723,"kind":"organization","name":"Stoke Therapeutics, Inc.","symbol":"STOK"},"owners":[{"id":22218,"kind":"person","name":"Kaye Edward M. MD","position":1,"cik":"0001522780","reported_name":"Kaye Edward M. MD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Performance Stock Units","published_at":"2026-08-19T00:28:55.000Z","date":"2026-08-14","kind":"exercise","planned":false,"acquired":false,"shares":26250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"Each performance stock unit represents a right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Achievement of this performance stock unit award was certified on August 14, 2025.  Pursuant to the terms of the award agreement between the reporting person and the Issuer, half the award vested on August 14, 2025 and the remainder vests on August 14, 2026, subject to the reporting person's continued service to the Issuer on the relevant vesting date."}],"balance_after":0,"derivative":{"expiration_date":"2026-08-14","underlying":"Common Stock","underlying_shares":26250},"source":{"system":"sec-edgar","filing":"0001522780-26-000007","document":"form4-08192026_120851.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1623526/000152278026000007/form4-08192026_120851.xml","form_type":"4"}},{"id":683469,"issuer":{"id":1723,"kind":"organization","name":"Stoke Therapeutics, Inc.","symbol":"STOK"},"owners":[{"id":22218,"kind":"person","name":"Kaye Edward M. MD","position":1,"cik":"0001522780","reported_name":"Kaye Edward M. MD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-08-19T00:28:55.000Z","date":"2026-08-18","kind":"sale","planned":false,"acquired":false,"shares":637,"price":32.4681,"value":20682.1797,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transaction represents an Issuer mandated sale to satisfy tax withholding liabilities in connection with the vesting and settlement of restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $32.44 to $32.54 per share, inclusive."}],"balance_after":124557,"source":{"system":"sec-edgar","filing":"0001522780-26-000007","document":"form4-08192026_120851.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1623526/000152278026000007/form4-08192026_120851.xml","form_type":"4"}},{"id":683468,"issuer":{"id":1723,"kind":"organization","name":"Stoke Therapeutics, Inc.","symbol":"STOK"},"owners":[{"id":22218,"kind":"person","name":"Kaye Edward M. MD","position":1,"cik":"0001522780","reported_name":"Kaye Edward M. MD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-08-19T00:28:55.000Z","date":"2026-08-18","kind":"sale","planned":false,"acquired":false,"shares":11930,"price":32.0072,"value":381845.896,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transaction represents an Issuer mandated sale to satisfy tax withholding liabilities in connection with the vesting and settlement of restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $31.40 to $32.36 per share, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote and in footnote 3 of this Form 4."}],"balance_after":125194,"source":{"system":"sec-edgar","filing":"0001522780-26-000007","document":"form4-08192026_120851.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1623526/000152278026000007/form4-08192026_120851.xml","form_type":"4"}},{"id":683467,"issuer":{"id":1723,"kind":"organization","name":"Stoke Therapeutics, Inc.","symbol":"STOK"},"owners":[{"id":22218,"kind":"person","name":"Kaye Edward M. MD","position":1,"cik":"0001522780","reported_name":"Kaye Edward M. MD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-08-19T00:28:55.000Z","date":"2026-08-14","kind":"exercise","planned":false,"acquired":true,"shares":26250,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":137124,"source":{"system":"sec-edgar","filing":"0001522780-26-000007","document":"form4-08192026_120851.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1623526/000152278026000007/form4-08192026_120851.xml","form_type":"4"}},{"id":683465,"issuer":{"id":1723,"kind":"organization","name":"Stoke Therapeutics, Inc.","symbol":"STOK"},"owners":[{"id":22216,"kind":"person","name":"Allan Jonathan","position":1,"cik":"0001966716","reported_name":"Allan Jonathan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"GENERAL COUNSEL & CORP SEC"}}],"security":"Performance Stock Units","published_at":"2026-08-19T00:27:22.000Z","date":"2026-08-14","kind":"exercise","planned":false,"acquired":false,"shares":6000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"Each performance stock unit represents a right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Achievement of this performance stock unit award was certified on August 14, 2025.  Pursuant to the terms of the award agreement between the reporting person and the Issuer, half the award vested on August 14, 2025 and the remainder vests on August 14, 2026, subject to the reporting person's continued service to the Issuer on the relevant vesting date."}],"balance_after":0,"derivative":{"expiration_date":"2026-08-14","underlying":"Common Stock","underlying_shares":6000},"source":{"system":"sec-edgar","filing":"0001966716-26-000012","document":"form4-08192026_120818.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1623526/000196671626000012/form4-08192026_120818.xml","form_type":"4"}},{"id":683464,"issuer":{"id":1723,"kind":"organization","name":"Stoke Therapeutics, Inc.","symbol":"STOK"},"owners":[{"id":22216,"kind":"person","name":"Allan Jonathan","position":1,"cik":"0001966716","reported_name":"Allan Jonathan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"GENERAL COUNSEL & CORP SEC"}}],"security":"Common Stock","published_at":"2026-08-19T00:27:22.000Z","date":"2026-08-18","kind":"sale","planned":false,"acquired":false,"shares":145,"price":32.4681,"value":4707.8745,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transaction represents an Issuer mandated sale to satisfy tax withholding liabilities in connection with the vesting and settlement of restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $32.44 to $32.54 per share, inclusive."}],"balance_after":21225,"source":{"system":"sec-edgar","filing":"0001966716-26-000012","document":"form4-08192026_120818.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1623526/000196671626000012/form4-08192026_120818.xml","form_type":"4"}},{"id":683463,"issuer":{"id":1723,"kind":"organization","name":"Stoke Therapeutics, Inc.","symbol":"STOK"},"owners":[{"id":22216,"kind":"person","name":"Allan Jonathan","position":1,"cik":"0001966716","reported_name":"Allan Jonathan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"GENERAL COUNSEL & CORP SEC"}}],"security":"Common Stock","published_at":"2026-08-19T00:27:22.000Z","date":"2026-08-18","kind":"sale","planned":false,"acquired":false,"shares":2716,"price":32.0072,"value":86931.5552,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transaction represents an Issuer mandated sale to satisfy tax withholding liabilities in connection with the vesting and settlement of restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $31.40 to $32.36 per share, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote and in footnote 3 of this Form 4."}],"balance_after":21370,"source":{"system":"sec-edgar","filing":"0001966716-26-000012","document":"form4-08192026_120818.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1623526/000196671626000012/form4-08192026_120818.xml","form_type":"4"}},{"id":683462,"issuer":{"id":1723,"kind":"organization","name":"Stoke Therapeutics, Inc.","symbol":"STOK"},"owners":[{"id":22216,"kind":"person","name":"Allan Jonathan","position":1,"cik":"0001966716","reported_name":"Allan Jonathan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"GENERAL COUNSEL & CORP SEC"}}],"security":"Common Stock","published_at":"2026-08-19T00:27:22.000Z","date":"2026-08-14","kind":"exercise","planned":false,"acquired":true,"shares":6000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":24086,"source":{"system":"sec-edgar","filing":"0001966716-26-000012","document":"form4-08192026_120818.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1623526/000196671626000012/form4-08192026_120818.xml","form_type":"4"}},{"id":695795,"issuer":{"id":1723,"kind":"organization","name":"Stoke Therapeutics, Inc.","symbol":"STOK"},"owners":[{"id":1724,"kind":"person","name":"Ticho Barry","position":1,"cik":"0001780088","reported_name":"Ticho Barry","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF MEDICAL OFFICER"}}],"security":"Common Stock","published_at":"2026-08-05T20:17:39.000Z","date":"2026-08-03","kind":"sale","planned":true,"acquired":false,"shares":1269,"price":29.4539,"value":37376.9991,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 19, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $29.36 to $29.54 per share, inclusive."}],"balance_after":20422,"source":{"system":"sec-edgar","filing":"0001780088-26-000017","document":"form4-08052026_080835.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1780088/000178008826000017/form4-08052026_080835.xml","form_type":"4"}},{"id":695794,"issuer":{"id":1723,"kind":"organization","name":"Stoke Therapeutics, Inc.","symbol":"STOK"},"owners":[{"id":1724,"kind":"person","name":"Ticho Barry","position":1,"cik":"0001780088","reported_name":"Ticho Barry","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF MEDICAL OFFICER"}}],"security":"Common Stock","published_at":"2026-08-05T20:17:39.000Z","date":"2026-08-03","kind":"sale","planned":true,"acquired":false,"shares":5907,"price":28.9501,"value":171008.2407,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 19, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $28.36 to $29.35 per share, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote and in footnote 3 of this Form 4."}],"balance_after":21691,"source":{"system":"sec-edgar","filing":"0001780088-26-000017","document":"form4-08052026_080835.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1780088/000178008826000017/form4-08052026_080835.xml","form_type":"4"}},{"id":706835,"issuer":{"id":1723,"kind":"organization","name":"Stoke Therapeutics, Inc.","symbol":"STOK"},"owners":[{"id":29760,"kind":"person","name":"Harrison Seth Loring","position":1,"cik":"0001404955","reported_name":"Harrison Seth Loring","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-07-17T20:37:22.000Z","date":"2026-07-16","kind":"gift","planned":false,"acquired":true,"shares":17786,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transaction represents a gift, for no consideration, of shares of the Issuer's Common Stock, which is exempt from short-swing profit liability pursuant to Rule 16b-5 under the Exchange Act of 1934, as amended."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F10","text":"The option shall vest in full on the earlier of:  (i) June 3, 2027 or (ii) the date of the Issuer's next annual meeting of its stockholders, subject to the reporting person's continued service to the Issuer on the vesting date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The securities are directly held by the East Pillar 2026 Irrevocable Trust (the \"Trust\"). The reporting person is a member of the board of managers of the Trust's trustee and may be deemed to exercise voting discretion, as well as shared investment discretion, in such capacity.  The reporting person and certain of his immediate family members are beneficiaries of the Trust."}],"balance_after":17786,"derivative":{"exercise_price":29.46,"expiration_date":"2036-06-02","underlying":"Common Stock","underlying_shares":17786},"source":{"system":"sec-edgar","filing":"0001404955-26-000006","document":"form4-07172026_080716.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":16,"url":"https://www.sec.gov/Archives/edgar/data/1623526/000140495526000006/form4-07172026_080716.xml","form_type":"4"}},{"id":706834,"issuer":{"id":1723,"kind":"organization","name":"Stoke Therapeutics, Inc.","symbol":"STOK"},"owners":[{"id":29760,"kind":"person","name":"Harrison Seth Loring","position":1,"cik":"0001404955","reported_name":"Harrison Seth Loring","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-07-17T20:37:22.000Z","date":"2026-07-16","kind":"gift","planned":false,"acquired":false,"shares":17786,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transaction represents a gift, for no consideration, of shares of the Issuer's Common Stock, which is exempt from short-swing profit liability pursuant to Rule 16b-5 under the Exchange Act of 1934, as amended."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F10","text":"The option shall vest in full on the earlier of:  (i) June 3, 2027 or (ii) the date of the Issuer's next annual meeting of its stockholders, subject to the reporting person's continued service to the Issuer on the vesting date."}],"balance_after":0,"derivative":{"exercise_price":29.46,"expiration_date":"2036-06-02","underlying":"Common Stock","underlying_shares":17786},"source":{"system":"sec-edgar","filing":"0001404955-26-000006","document":"form4-07172026_080716.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":15,"url":"https://www.sec.gov/Archives/edgar/data/1623526/000140495526000006/form4-07172026_080716.xml","form_type":"4"}},{"id":706833,"issuer":{"id":1723,"kind":"organization","name":"Stoke Therapeutics, Inc.","symbol":"STOK"},"owners":[{"id":29760,"kind":"person","name":"Harrison Seth Loring","position":1,"cik":"0001404955","reported_name":"Harrison Seth Loring","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-07-17T20:37:22.000Z","date":"2026-07-16","kind":"gift","planned":false,"acquired":true,"shares":29747,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transaction represents a gift, for no consideration, of shares of the Issuer's Common Stock, which is exempt from short-swing profit liability pursuant to Rule 16b-5 under the Exchange Act of 1934, as amended."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F9","text":"This option is fully vested and exercisable.  Pursuant to the grant agreement between the Issuer and the reporting person, the award became fully vested on June 3, 2026."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The securities are directly held by the East Pillar 2026 Irrevocable Trust (the \"Trust\"). The reporting person is a member of the board of managers of the Trust's trustee and may be deemed to exercise voting discretion, as well as shared investment discretion, in such capacity.  The reporting person and certain of his immediate family members are beneficiaries of the Trust."}],"balance_after":29747,"derivative":{"exercise_price":10.9,"expiration_date":"2035-06-02","underlying":"Common Stock","underlying_shares":29747},"source":{"system":"sec-edgar","filing":"0001404955-26-000006","document":"form4-07172026_080716.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":14,"url":"https://www.sec.gov/Archives/edgar/data/1623526/000140495526000006/form4-07172026_080716.xml","form_type":"4"}},{"id":706832,"issuer":{"id":1723,"kind":"organization","name":"Stoke Therapeutics, Inc.","symbol":"STOK"},"owners":[{"id":29760,"kind":"person","name":"Harrison Seth Loring","position":1,"cik":"0001404955","reported_name":"Harrison Seth Loring","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-07-17T20:37:22.000Z","date":"2026-07-16","kind":"gift","planned":false,"acquired":false,"shares":29747,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transaction represents a gift, for no consideration, of shares of the Issuer's Common Stock, which is exempt from short-swing profit liability pursuant to Rule 16b-5 under the Exchange Act of 1934, as amended."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F9","text":"This option is fully vested and exercisable.  Pursuant to the grant agreement between the Issuer and the reporting person, the award became fully vested on June 3, 2026."}],"balance_after":0,"derivative":{"exercise_price":10.9,"expiration_date":"2035-06-02","underlying":"Common Stock","underlying_shares":29747},"source":{"system":"sec-edgar","filing":"0001404955-26-000006","document":"form4-07172026_080716.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":13,"url":"https://www.sec.gov/Archives/edgar/data/1623526/000140495526000006/form4-07172026_080716.xml","form_type":"4"}},{"id":706831,"issuer":{"id":1723,"kind":"organization","name":"Stoke Therapeutics, Inc.","symbol":"STOK"},"owners":[{"id":29760,"kind":"person","name":"Harrison Seth Loring","position":1,"cik":"0001404955","reported_name":"Harrison Seth Loring","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-07-17T20:37:22.000Z","date":"2026-07-16","kind":"gift","planned":false,"acquired":true,"shares":7639,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transaction represents a gift, for no consideration, of shares of the Issuer's Common Stock, which is exempt from short-swing profit liability pursuant to Rule 16b-5 under the Exchange Act of 1934, as amended."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"This option is fully vested and exercisable.  Pursuant to the grant agreement between the Issuer and the reporting person, the award became fully vested on June 3, 2025."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The securities are directly held by the East Pillar 2026 Irrevocable Trust (the \"Trust\"). The reporting person is a member of the board of managers of the Trust's trustee and may be deemed to exercise voting discretion, as well as shared investment discretion, in such capacity.  The reporting person and certain of his immediate family members are beneficiaries of the Trust."}],"balance_after":7639,"derivative":{"exercise_price":16.41,"expiration_date":"2034-06-04","underlying":"Common Stock","underlying_shares":7639},"source":{"system":"sec-edgar","filing":"0001404955-26-000006","document":"form4-07172026_080716.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/1623526/000140495526000006/form4-07172026_080716.xml","form_type":"4"}},{"id":706830,"issuer":{"id":1723,"kind":"organization","name":"Stoke Therapeutics, Inc.","symbol":"STOK"},"owners":[{"id":29760,"kind":"person","name":"Harrison Seth Loring","position":1,"cik":"0001404955","reported_name":"Harrison Seth Loring","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-07-17T20:37:22.000Z","date":"2026-07-16","kind":"gift","planned":false,"acquired":false,"shares":7639,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transaction represents a gift, for no consideration, of shares of the Issuer's Common Stock, which is exempt from short-swing profit liability pursuant to Rule 16b-5 under the Exchange Act of 1934, as amended."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"This option is fully vested and exercisable.  Pursuant to the grant agreement between the Issuer and the reporting person, the award became fully vested on June 3, 2025."}],"balance_after":0,"derivative":{"exercise_price":16.41,"expiration_date":"2034-06-04","underlying":"Common Stock","underlying_shares":7639},"source":{"system":"sec-edgar","filing":"0001404955-26-000006","document":"form4-07172026_080716.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1623526/000140495526000006/form4-07172026_080716.xml","form_type":"4"}},{"id":706829,"issuer":{"id":1723,"kind":"organization","name":"Stoke Therapeutics, Inc.","symbol":"STOK"},"owners":[{"id":29760,"kind":"person","name":"Harrison Seth Loring","position":1,"cik":"0001404955","reported_name":"Harrison Seth Loring","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-07-17T20:37:22.000Z","date":"2026-07-16","kind":"gift","planned":false,"acquired":true,"shares":19441,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transaction represents a gift, for no consideration, of shares of the Issuer's Common Stock, which is exempt from short-swing profit liability pursuant to Rule 16b-5 under the Exchange Act of 1934, as amended."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"This option is fully vested and exercisable.  Pursuant to the grant agreement between the Issuer and the reporting person, the award became fully vested on June 13, 2024."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The securities are directly held by the East Pillar 2026 Irrevocable Trust (the \"Trust\"). The reporting person is a member of the board of managers of the Trust's trustee and may be deemed to exercise voting discretion, as well as shared investment discretion, in such capacity.  The reporting person and certain of his immediate family members are beneficiaries of the Trust."}],"balance_after":19441,"derivative":{"exercise_price":12.46,"expiration_date":"2033-06-12","underlying":"Common Stock","underlying_shares":19441},"source":{"system":"sec-edgar","filing":"0001404955-26-000006","document":"form4-07172026_080716.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1623526/000140495526000006/form4-07172026_080716.xml","form_type":"4"}},{"id":706828,"issuer":{"id":1723,"kind":"organization","name":"Stoke Therapeutics, Inc.","symbol":"STOK"},"owners":[{"id":29760,"kind":"person","name":"Harrison Seth Loring","position":1,"cik":"0001404955","reported_name":"Harrison Seth Loring","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-07-17T20:37:22.000Z","date":"2026-07-16","kind":"gift","planned":false,"acquired":false,"shares":19441,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transaction represents a gift, for no consideration, of shares of the Issuer's Common Stock, which is exempt from short-swing profit liability pursuant to Rule 16b-5 under the Exchange Act of 1934, as amended."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"This option is fully vested and exercisable.  Pursuant to the grant agreement between the Issuer and the reporting person, the award became fully vested on June 13, 2024."}],"balance_after":0,"derivative":{"exercise_price":12.46,"expiration_date":"2033-06-12","underlying":"Common Stock","underlying_shares":19441},"source":{"system":"sec-edgar","filing":"0001404955-26-000006","document":"form4-07172026_080716.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1623526/000140495526000006/form4-07172026_080716.xml","form_type":"4"}},{"id":706827,"issuer":{"id":1723,"kind":"organization","name":"Stoke Therapeutics, Inc.","symbol":"STOK"},"owners":[{"id":29760,"kind":"person","name":"Harrison Seth Loring","position":1,"cik":"0001404955","reported_name":"Harrison Seth Loring","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-07-17T20:37:22.000Z","date":"2026-07-16","kind":"gift","planned":false,"acquired":true,"shares":21000,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transaction represents a gift, for no consideration, of shares of the Issuer's Common Stock, which is exempt from short-swing profit liability pursuant to Rule 16b-5 under the Exchange Act of 1934, as amended."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"This option is fully vested and exercisable.  Pursuant to the grant agreement between the Issuer and the reporting person, the award became fully vested on June 7, 2023."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The securities are directly held by the East Pillar 2026 Irrevocable Trust (the \"Trust\"). The reporting person is a member of the board of managers of the Trust's trustee and may be deemed to exercise voting discretion, as well as shared investment discretion, in such capacity.  The reporting person and certain of his immediate family members are beneficiaries of the Trust."}],"balance_after":21000,"derivative":{"exercise_price":12.96,"expiration_date":"2032-06-06","underlying":"Common Stock","underlying_shares":21000},"source":{"system":"sec-edgar","filing":"0001404955-26-000006","document":"form4-07172026_080716.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1623526/000140495526000006/form4-07172026_080716.xml","form_type":"4"}},{"id":706826,"issuer":{"id":1723,"kind":"organization","name":"Stoke Therapeutics, Inc.","symbol":"STOK"},"owners":[{"id":29760,"kind":"person","name":"Harrison Seth Loring","position":1,"cik":"0001404955","reported_name":"Harrison Seth Loring","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-07-17T20:37:22.000Z","date":"2026-07-16","kind":"gift","planned":false,"acquired":false,"shares":21000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transaction represents a gift, for no consideration, of shares of the Issuer's Common Stock, which is exempt from short-swing profit liability pursuant to Rule 16b-5 under the Exchange Act of 1934, as amended."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"This option is fully vested and exercisable.  Pursuant to the grant agreement between the Issuer and the reporting person, the award became fully vested on June 7, 2023."}],"balance_after":0,"derivative":{"exercise_price":12.96,"expiration_date":"2032-06-06","underlying":"Common Stock","underlying_shares":21000},"source":{"system":"sec-edgar","filing":"0001404955-26-000006","document":"form4-07172026_080716.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1623526/000140495526000006/form4-07172026_080716.xml","form_type":"4"}},{"id":706825,"issuer":{"id":1723,"kind":"organization","name":"Stoke Therapeutics, Inc.","symbol":"STOK"},"owners":[{"id":29760,"kind":"person","name":"Harrison Seth Loring","position":1,"cik":"0001404955","reported_name":"Harrison Seth Loring","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-07-17T20:37:22.000Z","date":"2026-07-16","kind":"gift","planned":false,"acquired":true,"shares":11650,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transaction represents a gift, for no consideration, of shares of the Issuer's Common Stock, which is exempt from short-swing profit liability pursuant to Rule 16b-5 under the Exchange Act of 1934, as amended."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"This option is fully vested and exercisable.  Pursuant to the grant agreement between the Issuer and the reporting person, the award became fully vested on June 8, 2022."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The securities are directly held by the East Pillar 2026 Irrevocable Trust (the \"Trust\"). The reporting person is a member of the board of managers of the Trust's trustee and may be deemed to exercise voting discretion, as well as shared investment discretion, in such capacity.  The reporting person and certain of his immediate family members are beneficiaries of the Trust."}],"balance_after":11650,"derivative":{"exercise_price":40.37,"expiration_date":"2031-06-07","underlying":"Common Stock","underlying_shares":11650},"source":{"system":"sec-edgar","filing":"0001404955-26-000006","document":"form4-07172026_080716.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1623526/000140495526000006/form4-07172026_080716.xml","form_type":"4"}},{"id":706824,"issuer":{"id":1723,"kind":"organization","name":"Stoke Therapeutics, Inc.","symbol":"STOK"},"owners":[{"id":29760,"kind":"person","name":"Harrison Seth Loring","position":1,"cik":"0001404955","reported_name":"Harrison Seth Loring","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-07-17T20:37:22.000Z","date":"2026-07-16","kind":"gift","planned":false,"acquired":false,"shares":11650,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transaction represents a gift, for no consideration, of shares of the Issuer's Common Stock, which is exempt from short-swing profit liability pursuant to Rule 16b-5 under the Exchange Act of 1934, as amended."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"This option is fully vested and exercisable.  Pursuant to the grant agreement between the Issuer and the reporting person, the award became fully vested on June 8, 2022."}],"balance_after":0,"derivative":{"exercise_price":40.37,"expiration_date":"2031-06-07","underlying":"Common Stock","underlying_shares":11650},"source":{"system":"sec-edgar","filing":"0001404955-26-000006","document":"form4-07172026_080716.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1623526/000140495526000006/form4-07172026_080716.xml","form_type":"4"}},{"id":706823,"issuer":{"id":1723,"kind":"organization","name":"Stoke Therapeutics, Inc.","symbol":"STOK"},"owners":[{"id":29760,"kind":"person","name":"Harrison Seth Loring","position":1,"cik":"0001404955","reported_name":"Harrison Seth Loring","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-07-17T20:37:22.000Z","date":"2026-07-16","kind":"gift","planned":false,"acquired":true,"shares":14777,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transaction represents a gift, for no consideration, of shares of the Issuer's Common Stock, which is exempt from short-swing profit liability pursuant to Rule 16b-5 under the Exchange Act of 1934, as amended."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"This option is fully vested and exercisable.  Pursuant to the grant agreement between the Issuer and the reporting person, the award became fully vested on June 3, 2021."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The securities are directly held by the East Pillar 2026 Irrevocable Trust (the \"Trust\"). The reporting person is a member of the board of managers of the Trust's trustee and may be deemed to exercise voting discretion, as well as shared investment discretion, in such capacity.  The reporting person and certain of his immediate family members are beneficiaries of the Trust."}],"balance_after":14777,"derivative":{"exercise_price":26.53,"expiration_date":"2030-06-02","underlying":"Common Stock","underlying_shares":14777},"source":{"system":"sec-edgar","filing":"0001404955-26-000006","document":"form4-07172026_080716.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1623526/000140495526000006/form4-07172026_080716.xml","form_type":"4"}},{"id":706822,"issuer":{"id":1723,"kind":"organization","name":"Stoke Therapeutics, Inc.","symbol":"STOK"},"owners":[{"id":29760,"kind":"person","name":"Harrison Seth Loring","position":1,"cik":"0001404955","reported_name":"Harrison Seth Loring","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-07-17T20:37:22.000Z","date":"2026-07-16","kind":"gift","planned":false,"acquired":false,"shares":14777,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transaction represents a gift, for no consideration, of shares of the Issuer's Common Stock, which is exempt from short-swing profit liability pursuant to Rule 16b-5 under the Exchange Act of 1934, as amended."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"This option is fully vested and exercisable.  Pursuant to the grant agreement between the Issuer and the reporting person, the award became fully vested on June 3, 2021."}],"balance_after":0,"derivative":{"exercise_price":26.53,"expiration_date":"2030-06-02","underlying":"Common Stock","underlying_shares":14777},"source":{"system":"sec-edgar","filing":"0001404955-26-000006","document":"form4-07172026_080716.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1623526/000140495526000006/form4-07172026_080716.xml","form_type":"4"}},{"id":706821,"issuer":{"id":1723,"kind":"organization","name":"Stoke Therapeutics, Inc.","symbol":"STOK"},"owners":[{"id":29760,"kind":"person","name":"Harrison Seth Loring","position":1,"cik":"0001404955","reported_name":"Harrison Seth Loring","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-07-17T20:37:22.000Z","date":"2026-07-16","kind":"gift","planned":false,"acquired":true,"shares":29555,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transaction represents a gift, for no consideration, of shares of the Issuer's Common Stock, which is exempt from short-swing profit liability pursuant to Rule 16b-5 under the Exchange Act of 1934, as amended."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option is fully vested and exercisable.  Pursuant to the grant agreement between the Issuer and the reporting person, the award became fully vested on March 21, 2022."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The securities are directly held by the East Pillar 2026 Irrevocable Trust (the \"Trust\"). The reporting person is a member of the board of managers of the Trust's trustee and may be deemed to exercise voting discretion, as well as shared investment discretion, in such capacity.  The reporting person and certain of his immediate family members are beneficiaries of the Trust."}],"balance_after":29555,"derivative":{"exercise_price":28.8,"expiration_date":"2029-09-09","underlying":"Common Stock","underlying_shares":29555},"source":{"system":"sec-edgar","filing":"0001404955-26-000006","document":"form4-07172026_080716.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1623526/000140495526000006/form4-07172026_080716.xml","form_type":"4"}},{"id":706820,"issuer":{"id":1723,"kind":"organization","name":"Stoke Therapeutics, Inc.","symbol":"STOK"},"owners":[{"id":29760,"kind":"person","name":"Harrison Seth Loring","position":1,"cik":"0001404955","reported_name":"Harrison Seth Loring","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-07-17T20:37:22.000Z","date":"2026-07-16","kind":"gift","planned":false,"acquired":false,"shares":29555,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transaction represents a gift, for no consideration, of shares of the Issuer's Common Stock, which is exempt from short-swing profit liability pursuant to Rule 16b-5 under the Exchange Act of 1934, as amended."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option is fully vested and exercisable.  Pursuant to the grant agreement between the Issuer and the reporting person, the award became fully vested on March 21, 2022."}],"balance_after":0,"derivative":{"exercise_price":28.8,"expiration_date":"2029-09-09","underlying":"Common Stock","underlying_shares":29555},"source":{"system":"sec-edgar","filing":"0001404955-26-000006","document":"form4-07172026_080716.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1623526/000140495526000006/form4-07172026_080716.xml","form_type":"4"}},{"id":706954,"issuer":{"id":1723,"kind":"organization","name":"Stoke Therapeutics, Inc.","symbol":"STOK"},"owners":[{"id":29777,"kind":"person","name":"McCauley Thomas","position":1,"cik":"0001858760","reported_name":"McCauley Thomas","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Scientific Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-07-17T20:35:58.000Z","date":"2026-07-15","kind":"grant","planned":false,"acquired":true,"shares":225000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option vests as to 1/4 of the total award on July 15, 2027, and as to 1/48 of the total award monthly thereafter, subject to the reporting person's continued service to the Issuer on each vesting date."}],"balance_after":225000,"derivative":{"exercise_price":29.91,"expiration_date":"2036-07-14","underlying":"Common Stock","underlying_shares":225000},"source":{"system":"sec-edgar","filing":"0001858760-26-000008","document":"form4-07172026_080754.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1858760/000185876026000008/form4-07172026_080754.xml","form_type":"4"}},{"id":715354,"issuer":{"id":1723,"kind":"organization","name":"Stoke Therapeutics, Inc.","symbol":"STOK"},"owners":[{"id":1724,"kind":"person","name":"Ticho Barry","position":1,"cik":"0001780088","reported_name":"Ticho Barry","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF MEDICAL OFFICER"}}],"security":"Common Stock","published_at":"2026-07-06T20:10:51.000Z","date":"2026-07-01","kind":"sale","planned":true,"acquired":false,"shares":500,"price":33.2678,"value":16633.9,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 19, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $33.23 to $33.37 per share, inclusive."}],"balance_after":27598,"source":{"system":"sec-edgar","filing":"0001780088-26-000015","document":"form4-07062026_080747.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1780088/000178008826000015/form4-07062026_080747.xml","form_type":"4"}},{"id":715353,"issuer":{"id":1723,"kind":"organization","name":"Stoke Therapeutics, Inc.","symbol":"STOK"},"owners":[{"id":1724,"kind":"person","name":"Ticho Barry","position":1,"cik":"0001780088","reported_name":"Ticho Barry","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF MEDICAL OFFICER"}}],"security":"Common Stock","published_at":"2026-07-06T20:10:51.000Z","date":"2026-07-01","kind":"sale","planned":true,"acquired":false,"shares":6728,"price":32.615,"value":219433.72,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 19, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $32.18 to $33.05 per share, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote and in footnote 3 of this Form 4."}],"balance_after":28098,"source":{"system":"sec-edgar","filing":"0001780088-26-000015","document":"form4-07062026_080747.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1780088/000178008826000015/form4-07062026_080747.xml","form_type":"4"}},{"id":732065,"issuer":{"id":1723,"kind":"organization","name":"Stoke Therapeutics, Inc.","symbol":"STOK"},"owners":[{"id":22216,"kind":"person","name":"Allan Jonathan","position":1,"cik":"0001966716","reported_name":"Allan Jonathan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"GENERAL COUNSEL & CORP SEC"}}],"security":"Common Stock","published_at":"2026-06-18T20:18:58.000Z","date":"2026-06-16","kind":"sale","planned":true,"acquired":false,"shares":1457,"price":29.95,"value":43637.15,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 10, 2025."}],"balance_after":18086,"source":{"system":"sec-edgar","filing":"0001966716-26-000010","document":"form4-06182026_080652.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1623526/000196671626000010/form4-06182026_080652.xml","form_type":"4"}},{"id":747887,"issuer":{"id":1723,"kind":"organization","name":"Stoke Therapeutics, Inc.","symbol":"STOK"},"owners":[{"id":29273,"kind":"person","name":"TZIANABOS ARTHUR","position":1,"cik":"0001586226","reported_name":"TZIANABOS ARTHUR","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (Right to Buy)","published_at":"2026-06-05T20:33:16.000Z","date":"2026-06-03","kind":"grant","planned":false,"acquired":true,"shares":17786,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option shall vest in full on the earlier of:  (i) June 3, 2027 or (ii) the date of the issuer's next annual meeting of its stockholders, subject to the reporting person's continued service to the issuer on the vesting date."}],"balance_after":17786,"derivative":{"exercise_price":29.46,"expiration_date":"2036-06-02","underlying":"Common Stock","underlying_shares":17786},"source":{"system":"sec-edgar","filing":"0001586226-26-000004","document":"form4-06052026_080612.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1623526/000158622626000004/form4-06052026_080612.xml","form_type":"4"}},{"id":747885,"issuer":{"id":1723,"kind":"organization","name":"Stoke Therapeutics, Inc.","symbol":"STOK"},"owners":[{"id":40913,"kind":"person","name":"Smith Julie","position":1,"cik":"0001557928","reported_name":"Smith Julie","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (Right to Buy)","published_at":"2026-06-05T20:31:41.000Z","date":"2026-06-03","kind":"grant","planned":false,"acquired":true,"shares":17786,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option shall vest in full on the earlier of:  (i) June 3, 2027 or (ii) the date of the issuer's next annual meeting of its stockholders, subject to the reporting person's continued service to the issuer on the vesting date."}],"balance_after":17786,"derivative":{"exercise_price":29.46,"expiration_date":"2036-06-02","underlying":"Common Stock","underlying_shares":17786},"source":{"system":"sec-edgar","filing":"0001557928-26-000002","document":"form4-06052026_080637.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1623526/000155792826000002/form4-06052026_080637.xml","form_type":"4"}},{"id":747938,"issuer":{"id":1723,"kind":"organization","name":"Stoke Therapeutics, Inc.","symbol":"STOK"},"owners":[{"id":40934,"kind":"person","name":"LEVIN ARTHUR A","position":1,"cik":"0001181556","reported_name":"LEVIN ARTHUR A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (Right to Buy)","published_at":"2026-06-05T20:30:37.000Z","date":"2026-06-03","kind":"grant","planned":false,"acquired":true,"shares":17786,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option shall vest in full on the earlier of:  (i) June 3, 2027 or (ii) the date of the issuer's next annual meeting of its stockholders, subject to the reporting person's continued service to the issuer on the vesting date."}],"balance_after":17786,"derivative":{"exercise_price":29.46,"expiration_date":"2036-06-02","underlying":"Common Stock","underlying_shares":17786},"source":{"system":"sec-edgar","filing":"0001181556-26-000007","document":"form4-06052026_080631.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1181556/000118155626000007/form4-06052026_080631.xml","form_type":"4"}},{"id":748095,"issuer":{"id":1723,"kind":"organization","name":"Stoke Therapeutics, Inc.","symbol":"STOK"},"owners":[{"id":40957,"kind":"person","name":"Krainer Adrian R.","position":1,"cik":"0001780081","reported_name":"Krainer Adrian R.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (Right to Buy)","published_at":"2026-06-05T20:29:24.000Z","date":"2026-06-03","kind":"grant","planned":false,"acquired":true,"shares":17786,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option shall vest in full on the earlier of:  (i) June 3, 2027 or (ii) the date of the issuer's next annual meeting of its stockholders, subject to the reporting person's continued service to the issuer on the vesting date."}],"balance_after":17786,"derivative":{"exercise_price":29.46,"expiration_date":"2036-06-02","underlying":"Common Stock","underlying_shares":17786},"source":{"system":"sec-edgar","filing":"0001780081-26-000006","document":"form4-06052026_080620.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1780081/000178008126000006/form4-06052026_080620.xml","form_type":"4"}},{"id":747886,"issuer":{"id":1723,"kind":"organization","name":"Stoke Therapeutics, Inc.","symbol":"STOK"},"owners":[{"id":22218,"kind":"person","name":"Kaye Edward M. MD","position":1,"cik":"0001522780","reported_name":"Kaye Edward M. MD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (Right to Buy)","published_at":"2026-06-05T20:27:57.000Z","date":"2026-06-03","kind":"grant","planned":false,"acquired":true,"shares":17786,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option shall vest in full on the earlier of:  (i) June 3, 2027 or (ii) the date of the issuer's next annual meeting of its stockholders, subject to the reporting person's continued service to the issuer on the vesting date."}],"balance_after":17786,"derivative":{"exercise_price":29.46,"expiration_date":"2036-06-02","underlying":"Common Stock","underlying_shares":17786},"source":{"system":"sec-edgar","filing":"0001522780-26-000004","document":"form4-06052026_080652.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1623526/000152278026000004/form4-06052026_080652.xml","form_type":"4"}},{"id":747884,"issuer":{"id":1723,"kind":"organization","name":"Stoke Therapeutics, Inc.","symbol":"STOK"},"owners":[{"id":29760,"kind":"person","name":"Harrison Seth Loring","position":1,"cik":"0001404955","reported_name":"Harrison Seth Loring","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (Right to Buy)","published_at":"2026-06-05T20:26:13.000Z","date":"2026-06-03","kind":"grant","planned":false,"acquired":true,"shares":17786,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option shall vest in full on the earlier of:  (i) June 3, 2027 or (ii) the date of the issuer's next annual meeting of its stockholders, subject to the reporting person's continued service to the issuer on the vesting date."}],"balance_after":17786,"derivative":{"exercise_price":29.46,"expiration_date":"2036-06-02","underlying":"Common Stock","underlying_shares":17786},"source":{"system":"sec-edgar","filing":"0001404955-26-000002","document":"form4-06052026_080609.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1623526/000140495526000002/form4-06052026_080609.xml","form_type":"4"}},{"id":747883,"issuer":{"id":1723,"kind":"organization","name":"Stoke Therapeutics, Inc.","symbol":"STOK"},"owners":[{"id":40912,"kind":"person","name":"Burstein Jennifer","position":1,"cik":"0001640069","reported_name":"Burstein Jennifer","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (Right to Buy)","published_at":"2026-06-05T20:24:25.000Z","date":"2026-06-03","kind":"grant","planned":false,"acquired":true,"shares":17786,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option shall vest in full on the earlier of:  (i) June 3, 2027 or (ii) the date of the issuer's next annual meeting of its stockholders, subject to the reporting person's continued service to the issuer on the vesting date."}],"balance_after":17786,"derivative":{"exercise_price":29.46,"expiration_date":"2036-06-02","underlying":"Common Stock","underlying_shares":17786},"source":{"system":"sec-edgar","filing":"0001640069-26-000002","document":"form4-06052026_080621.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1623526/000164006926000002/form4-06052026_080621.xml","form_type":"4"}},{"id":751879,"issuer":{"id":1723,"kind":"organization","name":"Stoke Therapeutics, Inc.","symbol":"STOK"},"owners":[{"id":1724,"kind":"person","name":"Ticho Barry","position":1,"cik":"0001780088","reported_name":"Ticho Barry","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF MEDICAL OFFICER"}}],"security":"Common Stock","published_at":"2026-06-03T21:33:45.000Z","date":"2026-06-01","kind":"sale","planned":true,"acquired":false,"shares":1795,"price":30.58,"value":54891.1,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 19, 2025."}],"balance_after":34826,"source":{"system":"sec-edgar","filing":"0001780088-26-000013","document":"form4-06032026_090641.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1780088/000178008826000013/form4-06032026_090641.xml","form_type":"4"}},{"id":791790,"issuer":{"id":1723,"kind":"organization","name":"Stoke Therapeutics, Inc.","symbol":"STOK"},"owners":[{"id":1724,"kind":"person","name":"Ticho Barry","position":1,"cik":"0001780088","reported_name":"Ticho Barry","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF MEDICAL OFFICER"}}],"security":"Common Stock","published_at":"2026-05-05T20:18:28.000Z","date":"2026-05-01","kind":"sale","planned":true,"acquired":false,"shares":2243,"price":32.79,"value":73547.97,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 19, 2025."}],"balance_after":36621,"source":{"system":"sec-edgar","filing":"0001780088-26-000011","document":"form4-05052026_080522.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1780088/000178008826000011/form4-05052026_080522.xml","form_type":"4"}},{"id":813412,"issuer":{"id":1723,"kind":"organization","name":"Stoke Therapeutics, Inc.","symbol":"STOK"},"owners":[{"id":39284,"kind":"person","name":"Kahn Clare","position":1,"cik":"0001849236","reported_name":"Kahn Clare","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-04-07T23:09:14.000Z","date":"2026-04-03","kind":"grant","planned":false,"acquired":true,"shares":30782,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option award shall vest as to 1/12 of the total award quarterly on the first calendar day of each July, October, January, and April, with the first tranche vesting on July 1, 2026, subject to the reporting person's continued service to the Issuer through each vesting date."}],"balance_after":30782,"derivative":{"exercise_price":32.79,"expiration_date":"2036-04-02","underlying":"Common Stock","underlying_shares":30782},"source":{"system":"sec-edgar","filing":"0001849236-26-000004","document":"form4-04072026_110410.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1623526/000184923626000004/form4-04072026_110410.xml","form_type":"4"}},{"id":816568,"issuer":{"id":1723,"kind":"organization","name":"Stoke Therapeutics, Inc.","symbol":"STOK"},"owners":[{"id":1724,"kind":"person","name":"Ticho Barry","position":1,"cik":"0001780088","reported_name":"Ticho Barry","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF MEDICAL OFFICER"}}],"security":"Common Stock","published_at":"2026-04-03T20:12:37.000Z","date":"2026-04-01","kind":"sale","planned":true,"acquired":false,"shares":1838,"price":32.66,"value":60029.08,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 19, 2025."}],"balance_after":38864,"source":{"system":"sec-edgar","filing":"0001780088-26-000009","document":"form4-04032026_080432.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1780088/000178008826000009/form4-04032026_080432.xml","form_type":"4"}},{"id":829251,"issuer":{"id":1723,"kind":"organization","name":"Stoke Therapeutics, Inc.","symbol":"STOK"},"owners":[{"id":22216,"kind":"person","name":"Allan Jonathan","position":1,"cik":"0001966716","reported_name":"Allan Jonathan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"GENERAL COUNSEL & CORP SEC"}}],"security":"Common Stock","published_at":"2026-03-24T20:19:20.000Z","date":"2026-03-20","kind":"sale","planned":true,"acquired":false,"shares":601,"price":34.4079,"value":20679.1479,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 10, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $34.34 to $35.12 per share, inclusive."}],"balance_after":19543,"source":{"system":"sec-edgar","filing":"0001966716-26-000008","document":"form4-03242026_080316.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1623526/000196671626000008/form4-03242026_080316.xml","form_type":"4"}},{"id":829250,"issuer":{"id":1723,"kind":"organization","name":"Stoke Therapeutics, Inc.","symbol":"STOK"},"owners":[{"id":22216,"kind":"person","name":"Allan Jonathan","position":1,"cik":"0001966716","reported_name":"Allan Jonathan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"GENERAL COUNSEL & CORP SEC"}}],"security":"Common Stock","published_at":"2026-03-24T20:19:20.000Z","date":"2026-03-20","kind":"sale","planned":true,"acquired":false,"shares":8692,"price":33.6354,"value":292358.8968,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 10, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $33.33 to $34.28 per share, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote and in footnote 3 of this Form 4."}],"balance_after":20144,"source":{"system":"sec-edgar","filing":"0001966716-26-000008","document":"form4-03242026_080316.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1623526/000196671626000008/form4-03242026_080316.xml","form_type":"4"}},{"id":833560,"issuer":{"id":1723,"kind":"organization","name":"Stoke Therapeutics, Inc.","symbol":"STOK"},"owners":[{"id":1724,"kind":"person","name":"Ticho Barry","position":1,"cik":"0001780088","reported_name":"Ticho Barry","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF MEDICAL OFFICER"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-03-19T22:01:54.000Z","date":"2026-03-19","kind":"exercise","planned":true,"acquired":false,"shares":1365,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F6","text":"This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 19, 2025."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"The option is fully vested and exercisable."}],"balance_after":83035,"derivative":{"exercise_price":2.19,"expiration_date":"2028-12-11","underlying":"Common Stock","underlying_shares":1365},"source":{"system":"sec-edgar","filing":"0001780088-26-000006","document":"form4-03192026_100350.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1780088/000178008826000006/form4-03192026_100350.xml","form_type":"4"}},{"id":833559,"issuer":{"id":1723,"kind":"organization","name":"Stoke Therapeutics, Inc.","symbol":"STOK"},"owners":[{"id":1724,"kind":"person","name":"Ticho Barry","position":1,"cik":"0001780088","reported_name":"Ticho Barry","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF MEDICAL OFFICER"}}],"security":"Common Stock","published_at":"2026-03-19T22:01:54.000Z","date":"2026-03-19","kind":"sale","planned":true,"acquired":false,"shares":1461,"price":29.99,"value":43815.39,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F6","text":"This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 19, 2025."}],"balance_after":40702,"source":{"system":"sec-edgar","filing":"0001780088-26-000006","document":"form4-03192026_100350.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1780088/000178008826000006/form4-03192026_100350.xml","form_type":"4"}},{"id":833558,"issuer":{"id":1723,"kind":"organization","name":"Stoke Therapeutics, Inc.","symbol":"STOK"},"owners":[{"id":1724,"kind":"person","name":"Ticho Barry","position":1,"cik":"0001780088","reported_name":"Ticho Barry","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF MEDICAL OFFICER"}}],"security":"Common Stock","published_at":"2026-03-19T22:01:54.000Z","date":"2026-03-19","kind":"exercise","planned":true,"acquired":true,"shares":1365,"price":2.19,"value":2989.35,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F6","text":"This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 19, 2025."}],"balance_after":42163,"source":{"system":"sec-edgar","filing":"0001780088-26-000006","document":"form4-03192026_100350.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1780088/000178008826000006/form4-03192026_100350.xml","form_type":"4"}},{"id":833557,"issuer":{"id":1723,"kind":"organization","name":"Stoke Therapeutics, Inc.","symbol":"STOK"},"owners":[{"id":1724,"kind":"person","name":"Ticho Barry","position":1,"cik":"0001780088","reported_name":"Ticho Barry","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF MEDICAL OFFICER"}}],"security":"Common Stock","published_at":"2026-03-19T22:01:54.000Z","date":"2026-03-18","kind":"sale","planned":true,"acquired":false,"shares":103,"price":32.85,"value":3383.55,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transaction represents an Issuer mandated sale to satisfy tax withholding liabilities in connection with the vesting and settlement of restricted stock units."}],"balance_after":40798,"source":{"system":"sec-edgar","filing":"0001780088-26-000006","document":"form4-03192026_100350.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1780088/000178008826000006/form4-03192026_100350.xml","form_type":"4"}},{"id":833556,"issuer":{"id":1723,"kind":"organization","name":"Stoke Therapeutics, Inc.","symbol":"STOK"},"owners":[{"id":1724,"kind":"person","name":"Ticho Barry","position":1,"cik":"0001780088","reported_name":"Ticho Barry","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF MEDICAL OFFICER"}}],"security":"Common Stock","published_at":"2026-03-19T22:01:54.000Z","date":"2026-03-18","kind":"sale","planned":true,"acquired":false,"shares":483,"price":31.7888,"value":15353.9904,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transaction represents an Issuer mandated sale to satisfy tax withholding liabilities in connection with the vesting and settlement of restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $31.60 to $32.46 per share, inclusive."}],"balance_after":40901,"source":{"system":"sec-edgar","filing":"0001780088-26-000006","document":"form4-03192026_100350.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1780088/000178008826000006/form4-03192026_100350.xml","form_type":"4"}},{"id":833555,"issuer":{"id":1723,"kind":"organization","name":"Stoke Therapeutics, Inc.","symbol":"STOK"},"owners":[{"id":1724,"kind":"person","name":"Ticho Barry","position":1,"cik":"0001780088","reported_name":"Ticho Barry","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF MEDICAL OFFICER"}}],"security":"Common Stock","published_at":"2026-03-19T22:01:54.000Z","date":"2026-03-18","kind":"sale","planned":true,"acquired":false,"shares":6100,"price":31.2838,"value":190831.18,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transaction represents an Issuer mandated sale to satisfy tax withholding liabilities in connection with the vesting and settlement of restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $30.59 to $31.58 per share, inclusive."}],"balance_after":41384,"source":{"system":"sec-edgar","filing":"0001780088-26-000006","document":"form4-03192026_100350.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1780088/000178008826000006/form4-03192026_100350.xml","form_type":"4"}},{"id":833554,"issuer":{"id":1723,"kind":"organization","name":"Stoke Therapeutics, Inc.","symbol":"STOK"},"owners":[{"id":1724,"kind":"person","name":"Ticho Barry","position":1,"cik":"0001780088","reported_name":"Ticho Barry","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF MEDICAL OFFICER"}}],"security":"Common Stock","published_at":"2026-03-19T22:01:54.000Z","date":"2026-03-17","kind":"sale","planned":true,"acquired":false,"shares":2587,"price":33.3754,"value":86342.1598,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transaction represents an Issuer mandated sale to satisfy tax withholding liabilities in connection with the vesting and settlement of restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $33.00 to $33.855 per share, inclusive."}],"balance_after":47484,"source":{"system":"sec-edgar","filing":"0001780088-26-000006","document":"form4-03192026_100350.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1780088/000178008826000006/form4-03192026_100350.xml","form_type":"4"}},{"id":833553,"issuer":{"id":1723,"kind":"organization","name":"Stoke Therapeutics, Inc.","symbol":"STOK"},"owners":[{"id":1724,"kind":"person","name":"Ticho Barry","position":1,"cik":"0001780088","reported_name":"Ticho Barry","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF MEDICAL OFFICER"}}],"security":"Common Stock","published_at":"2026-03-19T22:01:54.000Z","date":"2026-03-17","kind":"sale","planned":true,"acquired":false,"shares":3577,"price":32.7394,"value":117108.8338,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transaction represents an Issuer mandated sale to satisfy tax withholding liabilities in connection with the vesting and settlement of restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $31.995 to $32.99 per share, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote and in footnotes 3 through 5 of this Form 4."}],"balance_after":50071,"source":{"system":"sec-edgar","filing":"0001780088-26-000006","document":"form4-03192026_100350.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1780088/000178008826000006/form4-03192026_100350.xml","form_type":"4"}},{"id":833452,"issuer":{"id":1723,"kind":"organization","name":"Stoke Therapeutics, Inc.","symbol":"STOK"},"owners":[{"id":57125,"kind":"person","name":"Leggett Thomas","position":1,"cik":"0001774690","reported_name":"Leggett Thomas","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-03-19T22:00:39.000Z","date":"2026-03-18","kind":"sale","planned":false,"acquired":false,"shares":37,"price":32.85,"value":1215.45,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transaction represents an Issuer mandated sale to satisfy tax withholding liabilities in connection with the vesting and settlement of restricted stock units."}],"balance_after":10172,"source":{"system":"sec-edgar","filing":"0001774690-26-000006","document":"form4-03192026_100335.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1623526/000177469026000006/form4-03192026_100335.xml","form_type":"4"}},{"id":833451,"issuer":{"id":1723,"kind":"organization","name":"Stoke Therapeutics, Inc.","symbol":"STOK"},"owners":[{"id":57125,"kind":"person","name":"Leggett Thomas","position":1,"cik":"0001774690","reported_name":"Leggett Thomas","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-03-19T22:00:39.000Z","date":"2026-03-18","kind":"sale","planned":false,"acquired":false,"shares":172,"price":31.7888,"value":5467.6736,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transaction represents an Issuer mandated sale to satisfy tax withholding liabilities in connection with the vesting and settlement of restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $31.60 to $32.46 per share, inclusive."}],"balance_after":10209,"source":{"system":"sec-edgar","filing":"0001774690-26-000006","document":"form4-03192026_100335.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1623526/000177469026000006/form4-03192026_100335.xml","form_type":"4"}},{"id":833450,"issuer":{"id":1723,"kind":"organization","name":"Stoke Therapeutics, Inc.","symbol":"STOK"},"owners":[{"id":57125,"kind":"person","name":"Leggett Thomas","position":1,"cik":"0001774690","reported_name":"Leggett Thomas","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-03-19T22:00:39.000Z","date":"2026-03-18","kind":"sale","planned":false,"acquired":false,"shares":2173,"price":31.2838,"value":67979.6974,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transaction represents an Issuer mandated sale to satisfy tax withholding liabilities in connection with the vesting and settlement of restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $30.59 to $31.58 per share, inclusive."}],"balance_after":10381,"source":{"system":"sec-edgar","filing":"0001774690-26-000006","document":"form4-03192026_100335.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1623526/000177469026000006/form4-03192026_100335.xml","form_type":"4"}},{"id":833449,"issuer":{"id":1723,"kind":"organization","name":"Stoke Therapeutics, Inc.","symbol":"STOK"},"owners":[{"id":57125,"kind":"person","name":"Leggett Thomas","position":1,"cik":"0001774690","reported_name":"Leggett Thomas","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-03-19T22:00:39.000Z","date":"2026-03-17","kind":"sale","planned":false,"acquired":false,"shares":922,"price":33.3754,"value":30772.1188,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transaction represents an Issuer mandated sale to satisfy tax withholding liabilities in connection with the vesting and settlement of restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $33.00 to $33.855 per share, inclusive."}],"balance_after":12554,"source":{"system":"sec-edgar","filing":"0001774690-26-000006","document":"form4-03192026_100335.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1623526/000177469026000006/form4-03192026_100335.xml","form_type":"4"}},{"id":833448,"issuer":{"id":1723,"kind":"organization","name":"Stoke Therapeutics, Inc.","symbol":"STOK"},"owners":[{"id":57125,"kind":"person","name":"Leggett Thomas","position":1,"cik":"0001774690","reported_name":"Leggett Thomas","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-03-19T22:00:39.000Z","date":"2026-03-17","kind":"sale","planned":false,"acquired":false,"shares":1274,"price":32.7394,"value":41709.9956,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transaction represents an Issuer mandated sale to satisfy tax withholding liabilities in connection with the vesting and settlement of restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $31.995 to $32.99 per share, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote and in footnotes 3 through 5 of this Form 4."}],"balance_after":13476,"source":{"system":"sec-edgar","filing":"0001774690-26-000006","document":"form4-03192026_100335.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1623526/000177469026000006/form4-03192026_100335.xml","form_type":"4"}},{"id":833441,"issuer":{"id":1723,"kind":"organization","name":"Stoke Therapeutics, Inc.","symbol":"STOK"},"owners":[{"id":57124,"kind":"person","name":"Hoitt Jason","position":1,"cik":"0001762572","reported_name":"Hoitt Jason","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Patient Officer"}}],"security":"Common Stock","published_at":"2026-03-19T21:58:41.000Z","date":"2026-03-18","kind":"sale","planned":false,"acquired":false,"shares":30,"price":32.85,"value":985.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transaction represents an Issuer mandated sale to satisfy tax withholding liabilities in connection with the vesting and settlement of restricted stock units."}],"balance_after":10276,"source":{"system":"sec-edgar","filing":"0001762572-26-000006","document":"form4-03192026_090337.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1623526/000176257226000006/form4-03192026_090337.xml","form_type":"4"}},{"id":833440,"issuer":{"id":1723,"kind":"organization","name":"Stoke Therapeutics, Inc.","symbol":"STOK"},"owners":[{"id":57124,"kind":"person","name":"Hoitt Jason","position":1,"cik":"0001762572","reported_name":"Hoitt Jason","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Patient Officer"}}],"security":"Common Stock","published_at":"2026-03-19T21:58:41.000Z","date":"2026-03-18","kind":"sale","planned":false,"acquired":false,"shares":139,"price":31.7888,"value":4418.6432,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transaction represents an Issuer mandated sale to satisfy tax withholding liabilities in connection with the vesting and settlement of restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $31.60 to $32.46 per share, inclusive."}],"balance_after":10306,"source":{"system":"sec-edgar","filing":"0001762572-26-000006","document":"form4-03192026_090337.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1623526/000176257226000006/form4-03192026_090337.xml","form_type":"4"}},{"id":833439,"issuer":{"id":1723,"kind":"organization","name":"Stoke Therapeutics, Inc.","symbol":"STOK"},"owners":[{"id":57124,"kind":"person","name":"Hoitt Jason","position":1,"cik":"0001762572","reported_name":"Hoitt Jason","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Patient Officer"}}],"security":"Common Stock","published_at":"2026-03-19T21:58:41.000Z","date":"2026-03-18","kind":"sale","planned":false,"acquired":false,"shares":1762,"price":31.2838,"value":55122.0556,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transaction represents an Issuer mandated sale to satisfy tax withholding liabilities in connection with the vesting and settlement of restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $30.59 to $31.58 per share, inclusive."}],"balance_after":10445,"source":{"system":"sec-edgar","filing":"0001762572-26-000006","document":"form4-03192026_090337.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1623526/000176257226000006/form4-03192026_090337.xml","form_type":"4"}},{"id":833438,"issuer":{"id":1723,"kind":"organization","name":"Stoke Therapeutics, Inc.","symbol":"STOK"},"owners":[{"id":57124,"kind":"person","name":"Hoitt Jason","position":1,"cik":"0001762572","reported_name":"Hoitt Jason","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Patient Officer"}}],"security":"Common Stock","published_at":"2026-03-19T21:58:41.000Z","date":"2026-03-17","kind":"sale","planned":false,"acquired":false,"shares":748,"price":33.3754,"value":24964.7992,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transaction represents an Issuer mandated sale to satisfy tax withholding liabilities in connection with the vesting and settlement of restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $33.00 to $33.855 per share, inclusive."}],"balance_after":12207,"source":{"system":"sec-edgar","filing":"0001762572-26-000006","document":"form4-03192026_090337.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1623526/000176257226000006/form4-03192026_090337.xml","form_type":"4"}},{"id":833437,"issuer":{"id":1723,"kind":"organization","name":"Stoke Therapeutics, Inc.","symbol":"STOK"},"owners":[{"id":57124,"kind":"person","name":"Hoitt Jason","position":1,"cik":"0001762572","reported_name":"Hoitt Jason","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Patient Officer"}}],"security":"Common Stock","published_at":"2026-03-19T21:58:41.000Z","date":"2026-03-17","kind":"sale","planned":false,"acquired":false,"shares":1033,"price":32.7394,"value":33819.8002,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transaction represents an Issuer mandated sale to satisfy tax withholding liabilities in connection with the vesting and settlement of restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $31.995 to $32.99 per share, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote and in footnotes 3 through 5 of this Form 4."}],"balance_after":12955,"source":{"system":"sec-edgar","filing":"0001762572-26-000006","document":"form4-03192026_090337.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1623526/000176257226000006/form4-03192026_090337.xml","form_type":"4"}},{"id":833436,"issuer":{"id":1723,"kind":"organization","name":"Stoke Therapeutics, Inc.","symbol":"STOK"},"owners":[{"id":22216,"kind":"person","name":"Allan Jonathan","position":1,"cik":"0001966716","reported_name":"Allan Jonathan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"GENERAL COUNSEL & CORP SEC"}}],"security":"Common Stock","published_at":"2026-03-19T21:57:09.000Z","date":"2026-03-18","kind":"sale","planned":false,"acquired":false,"shares":72,"price":32.85,"value":2365.2,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transaction represents an Issuer mandated sale to satisfy tax withholding liabilities in connection with the vesting and settlement of restricted stock units."}],"balance_after":28836,"source":{"system":"sec-edgar","filing":"0001966716-26-000006","document":"form4-03192026_090304.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1623526/000196671626000006/form4-03192026_090304.xml","form_type":"4"}},{"id":833435,"issuer":{"id":1723,"kind":"organization","name":"Stoke Therapeutics, Inc.","symbol":"STOK"},"owners":[{"id":22216,"kind":"person","name":"Allan Jonathan","position":1,"cik":"0001966716","reported_name":"Allan Jonathan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"GENERAL COUNSEL & CORP SEC"}}],"security":"Common Stock","published_at":"2026-03-19T21:57:09.000Z","date":"2026-03-18","kind":"sale","planned":false,"acquired":false,"shares":334,"price":31.7888,"value":10617.4592,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transaction represents an Issuer mandated sale to satisfy tax withholding liabilities in connection with the vesting and settlement of restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $31.60 to $32.46 per share, inclusive."}],"balance_after":28908,"source":{"system":"sec-edgar","filing":"0001966716-26-000006","document":"form4-03192026_090304.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1623526/000196671626000006/form4-03192026_090304.xml","form_type":"4"}},{"id":833434,"issuer":{"id":1723,"kind":"organization","name":"Stoke Therapeutics, Inc.","symbol":"STOK"},"owners":[{"id":22216,"kind":"person","name":"Allan Jonathan","position":1,"cik":"0001966716","reported_name":"Allan Jonathan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"GENERAL COUNSEL & CORP SEC"}}],"security":"Common Stock","published_at":"2026-03-19T21:57:09.000Z","date":"2026-03-18","kind":"sale","planned":false,"acquired":false,"shares":4222,"price":31.2838,"value":132080.2036,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transaction represents an Issuer mandated sale to satisfy tax withholding liabilities in connection with the vesting and settlement of restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $30.59 to $31.58 per share, inclusive."}],"balance_after":29242,"source":{"system":"sec-edgar","filing":"0001966716-26-000006","document":"form4-03192026_090304.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1623526/000196671626000006/form4-03192026_090304.xml","form_type":"4"}},{"id":833433,"issuer":{"id":1723,"kind":"organization","name":"Stoke Therapeutics, Inc.","symbol":"STOK"},"owners":[{"id":22216,"kind":"person","name":"Allan Jonathan","position":1,"cik":"0001966716","reported_name":"Allan Jonathan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"GENERAL COUNSEL & CORP SEC"}}],"security":"Common Stock","published_at":"2026-03-19T21:57:09.000Z","date":"2026-03-17","kind":"sale","planned":false,"acquired":false,"shares":1791,"price":33.3754,"value":59775.3414,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transaction represents an Issuer mandated sale to satisfy tax withholding liabilities in connection with the vesting and settlement of restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $33.00 to $33.855 per share, inclusive."}],"balance_after":33464,"source":{"system":"sec-edgar","filing":"0001966716-26-000006","document":"form4-03192026_090304.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1623526/000196671626000006/form4-03192026_090304.xml","form_type":"4"}},{"id":833432,"issuer":{"id":1723,"kind":"organization","name":"Stoke Therapeutics, Inc.","symbol":"STOK"},"owners":[{"id":22216,"kind":"person","name":"Allan Jonathan","position":1,"cik":"0001966716","reported_name":"Allan Jonathan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"GENERAL COUNSEL & CORP SEC"}}],"security":"Common Stock","published_at":"2026-03-19T21:57:09.000Z","date":"2026-03-17","kind":"sale","planned":false,"acquired":false,"shares":2476,"price":32.7394,"value":81062.7544,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported transaction represents an Issuer mandated sale to satisfy tax withholding liabilities in connection with the vesting and settlement of restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $31.995 to $32.99 per share, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote and in footnotes 3 through 5 of this Form 4."}],"balance_after":35255,"source":{"system":"sec-edgar","filing":"0001966716-26-000006","document":"form4-03192026_090304.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1623526/000196671626000006/form4-03192026_090304.xml","form_type":"4"}},{"id":837853,"issuer":{"id":1723,"kind":"organization","name":"Stoke Therapeutics, Inc.","symbol":"STOK"},"owners":[{"id":57124,"kind":"person","name":"Hoitt Jason","position":1,"cik":"0001762572","reported_name":"Hoitt Jason","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Patient Officer"}}],"security":"Restricted Stock Units","published_at":"2026-03-17T21:26:50.000Z","date":"2026-03-15","kind":"exercise","planned":false,"acquired":false,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one (1) share of the Issuer's Common Stock upon settlement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The award vested or vests as to 1/4 of the total award annually beginning on March 15, 2026, subject to the reporting person's continued service to the Issuer through each vesting date."}],"balance_after":30000,"derivative":{"expiration_date":"2029-03-15","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001762572-26-000004","document":"form4-03172026_090347.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1623526/000176257226000004/form4-03172026_090347.xml","form_type":"4"}},{"id":837852,"issuer":{"id":1723,"kind":"organization","name":"Stoke Therapeutics, Inc.","symbol":"STOK"},"owners":[{"id":57124,"kind":"person","name":"Hoitt Jason","position":1,"cik":"0001762572","reported_name":"Hoitt Jason","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Patient Officer"}}],"security":"Common Stock","published_at":"2026-03-17T21:26:50.000Z","date":"2026-03-15","kind":"exercise","planned":false,"acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"The reported total includes an aggregate 2,186 shares acquired pursuant to the Issuer's Employee Stock Purchase Plan in one or more transactions exempt pursuant to Rules 16b-3(c) and 16b-3(d)."}],"balance_after":13988,"source":{"system":"sec-edgar","filing":"0001762572-26-000004","document":"form4-03172026_090347.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1623526/000176257226000004/form4-03172026_090347.xml","form_type":"4"}},{"id":837855,"issuer":{"id":1723,"kind":"organization","name":"Stoke Therapeutics, Inc.","symbol":"STOK"},"owners":[{"id":57125,"kind":"person","name":"Leggett Thomas","position":1,"cik":"0001774690","reported_name":"Leggett Thomas","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Restricted Stock Units","published_at":"2026-03-17T21:26:02.000Z","date":"2026-03-15","kind":"exercise","planned":false,"acquired":false,"shares":14750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one (1) share of the Issuer's Common Stock upon settlement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The award vested or vests as to 1/4 of the total award annually beginning on March 15, 2026, subject to the reporting person's continued service to the Issuer through each vesting date."}],"balance_after":44250,"derivative":{"expiration_date":"2029-03-15","underlying":"Common Stock","underlying_shares":14750},"source":{"system":"sec-edgar","filing":"0001774690-26-000004","document":"form4-03172026_090359.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1623526/000177469026000004/form4-03172026_090359.xml","form_type":"4"}},{"id":837854,"issuer":{"id":1723,"kind":"organization","name":"Stoke Therapeutics, Inc.","symbol":"STOK"},"owners":[{"id":57125,"kind":"person","name":"Leggett Thomas","position":1,"cik":"0001774690","reported_name":"Leggett Thomas","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-03-17T21:26:02.000Z","date":"2026-03-15","kind":"exercise","planned":false,"acquired":true,"shares":14750,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":14750,"source":{"system":"sec-edgar","filing":"0001774690-26-000004","document":"form4-03172026_090359.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1623526/000177469026000004/form4-03172026_090359.xml","form_type":"4"}},{"id":838133,"issuer":{"id":1723,"kind":"organization","name":"Stoke Therapeutics, Inc.","symbol":"STOK"},"owners":[{"id":1724,"kind":"person","name":"Ticho Barry","position":1,"cik":"0001780088","reported_name":"Ticho Barry","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF MEDICAL OFFICER"}}],"security":"Restricted Stock Units","published_at":"2026-03-17T21:25:20.000Z","date":"2026-03-15","kind":"exercise","planned":false,"acquired":false,"shares":10750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one (1) share of the Issuer's Common Stock upon settlement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The award vested or vests as to 1/4 of the total award annually beginning on March 15, 2026, subject to the reporting person's continued service to the Issuer through each vesting date."}],"balance_after":32250,"derivative":{"expiration_date":"2029-03-15","underlying":"Common Stock","underlying_shares":10750},"source":{"system":"sec-edgar","filing":"0001780088-26-000004","document":"form4-03172026_090316.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1780088/000178008826000004/form4-03172026_090316.xml","form_type":"4"}},{"id":838132,"issuer":{"id":1723,"kind":"organization","name":"Stoke Therapeutics, Inc.","symbol":"STOK"},"owners":[{"id":1724,"kind":"person","name":"Ticho Barry","position":1,"cik":"0001780088","reported_name":"Ticho Barry","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF MEDICAL OFFICER"}}],"security":"Restricted Stock Units","published_at":"2026-03-17T21:25:20.000Z","date":"2026-03-15","kind":"exercise","planned":false,"acquired":false,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one (1) share of the Issuer's Common Stock upon settlement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The award vested or vests as to 1/4 of the total award annually beginning on March 15, 2025, subject to the reporting person's continued service to the Issuer through each vesting date."}],"balance_after":20000,"derivative":{"expiration_date":"2028-03-15","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001780088-26-000004","document":"form4-03172026_090316.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1780088/000178008826000004/form4-03172026_090316.xml","form_type":"4"}},{"id":838131,"issuer":{"id":1723,"kind":"organization","name":"Stoke Therapeutics, Inc.","symbol":"STOK"},"owners":[{"id":1724,"kind":"person","name":"Ticho Barry","position":1,"cik":"0001780088","reported_name":"Ticho Barry","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF MEDICAL OFFICER"}}],"security":"Restricted Stock Units","published_at":"2026-03-17T21:25:20.000Z","date":"2026-03-15","kind":"exercise","planned":false,"acquired":false,"shares":13100,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one (1) share of the Issuer's Common Stock upon settlement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The award vested or vests as to 1/4 of the total shares annually beginning March 15, 2024, subject to the reporting person's continued service to the Issuer through each vesting date."}],"balance_after":13100,"derivative":{"expiration_date":"2027-03-15","underlying":"Common Stock","underlying_shares":13100},"source":{"system":"sec-edgar","filing":"0001780088-26-000004","document":"form4-03172026_090316.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1780088/000178008826000004/form4-03172026_090316.xml","form_type":"4"}},{"id":838130,"issuer":{"id":1723,"kind":"organization","name":"Stoke Therapeutics, Inc.","symbol":"STOK"},"owners":[{"id":1724,"kind":"person","name":"Ticho Barry","position":1,"cik":"0001780088","reported_name":"Ticho Barry","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF MEDICAL OFFICER"}}],"security":"Common Stock","published_at":"2026-03-17T21:25:20.000Z","date":"2026-03-15","kind":"exercise","planned":false,"acquired":true,"shares":10750,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":53648,"source":{"system":"sec-edgar","filing":"0001780088-26-000004","document":"form4-03172026_090316.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1780088/000178008826000004/form4-03172026_090316.xml","form_type":"4"}},{"id":838129,"issuer":{"id":1723,"kind":"organization","name":"Stoke Therapeutics, Inc.","symbol":"STOK"},"owners":[{"id":1724,"kind":"person","name":"Ticho Barry","position":1,"cik":"0001780088","reported_name":"Ticho Barry","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF MEDICAL OFFICER"}}],"security":"Common Stock","published_at":"2026-03-17T21:25:20.000Z","date":"2026-03-15","kind":"exercise","planned":false,"acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":42898,"source":{"system":"sec-edgar","filing":"0001780088-26-000004","document":"form4-03172026_090316.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1780088/000178008826000004/form4-03172026_090316.xml","form_type":"4"}},{"id":838128,"issuer":{"id":1723,"kind":"organization","name":"Stoke Therapeutics, Inc.","symbol":"STOK"},"owners":[{"id":1724,"kind":"person","name":"Ticho Barry","position":1,"cik":"0001780088","reported_name":"Ticho Barry","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF MEDICAL OFFICER"}}],"security":"Common Stock","published_at":"2026-03-17T21:25:20.000Z","date":"2026-03-15","kind":"exercise","planned":false,"acquired":true,"shares":13100,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":32898,"source":{"system":"sec-edgar","filing":"0001780088-26-000004","document":"form4-03172026_090316.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1780088/000178008826000004/form4-03172026_090316.xml","form_type":"4"}},{"id":837851,"issuer":{"id":1723,"kind":"organization","name":"Stoke Therapeutics, Inc.","symbol":"STOK"},"owners":[{"id":22218,"kind":"person","name":"Kaye Edward M. MD","position":1,"cik":"0001522780","reported_name":"Kaye Edward M. MD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2026-03-17T21:24:32.000Z","date":"2026-03-15","kind":"exercise","planned":false,"acquired":false,"shares":26250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one (1) share of the Issuer's Common Stock upon settlement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The award vested or vests as to 1/4 of the total award annually beginning on March 15, 2025, subject to the reporting person's continued service to the Issuer through each vesting date."}],"balance_after":52500,"derivative":{"expiration_date":"2028-03-15","underlying":"Common Stock","underlying_shares":26250},"source":{"system":"sec-edgar","filing":"0001522780-26-000002","document":"form4-03172026_090329.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1623526/000152278026000002/form4-03172026_090329.xml","form_type":"4"}},{"id":837850,"issuer":{"id":1723,"kind":"organization","name":"Stoke Therapeutics, Inc.","symbol":"STOK"},"owners":[{"id":22218,"kind":"person","name":"Kaye Edward M. MD","position":1,"cik":"0001522780","reported_name":"Kaye Edward M. MD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2026-03-17T21:24:32.000Z","date":"2026-03-15","kind":"exercise","planned":false,"acquired":false,"shares":35500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one (1) share of the Issuer's Common Stock upon settlement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The award vested or vests as to 1/4 of the total shares annually beginning March 15, 2024, subject to the reporting person's continued service to the Issuer through each vesting date."}],"balance_after":35500,"derivative":{"expiration_date":"2027-03-15","underlying":"Common Stock","underlying_shares":35500},"source":{"system":"sec-edgar","filing":"0001522780-26-000002","document":"form4-03172026_090329.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1623526/000152278026000002/form4-03172026_090329.xml","form_type":"4"}},{"id":837849,"issuer":{"id":1723,"kind":"organization","name":"Stoke Therapeutics, Inc.","symbol":"STOK"},"owners":[{"id":22218,"kind":"person","name":"Kaye Edward M. MD","position":1,"cik":"0001522780","reported_name":"Kaye Edward M. MD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-03-17T21:24:32.000Z","date":"2026-03-15","kind":"exercise","planned":false,"acquired":true,"shares":26250,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":110874,"source":{"system":"sec-edgar","filing":"0001522780-26-000002","document":"form4-03172026_090329.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1623526/000152278026000002/form4-03172026_090329.xml","form_type":"4"}},{"id":837848,"issuer":{"id":1723,"kind":"organization","name":"Stoke Therapeutics, Inc.","symbol":"STOK"},"owners":[{"id":22218,"kind":"person","name":"Kaye Edward M. MD","position":1,"cik":"0001522780","reported_name":"Kaye Edward M. MD","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-03-17T21:24:32.000Z","date":"2026-03-15","kind":"exercise","planned":false,"acquired":true,"shares":35500,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":84624,"source":{"system":"sec-edgar","filing":"0001522780-26-000002","document":"form4-03172026_090329.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1623526/000152278026000002/form4-03172026_090329.xml","form_type":"4"}},{"id":837847,"issuer":{"id":1723,"kind":"organization","name":"Stoke Therapeutics, Inc.","symbol":"STOK"},"owners":[{"id":22216,"kind":"person","name":"Allan Jonathan","position":1,"cik":"0001966716","reported_name":"Allan Jonathan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"GENERAL COUNSEL & CORP SEC"}}],"security":"Restricted Stock Units","published_at":"2026-03-17T21:23:45.000Z","date":"2026-03-15","kind":"exercise","planned":false,"acquired":false,"shares":12000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one (1) share of the Issuer's Common Stock upon settlement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The award vested or vests as to 1/4 of the total award annually beginning on March 15, 2026, subject to the reporting person's continued service to the Issuer through each vesting date."}],"balance_after":36000,"derivative":{"expiration_date":"2029-03-15","underlying":"Common Stock","underlying_shares":12000},"source":{"system":"sec-edgar","filing":"0001966716-26-000004","document":"form4-03172026_090341.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1623526/000196671626000004/form4-03172026_090341.xml","form_type":"4"}},{"id":837846,"issuer":{"id":1723,"kind":"organization","name":"Stoke Therapeutics, Inc.","symbol":"STOK"},"owners":[{"id":22216,"kind":"person","name":"Allan Jonathan","position":1,"cik":"0001966716","reported_name":"Allan Jonathan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"GENERAL COUNSEL & CORP SEC"}}],"security":"Restricted Stock Units","published_at":"2026-03-17T21:23:45.000Z","date":"2026-03-15","kind":"exercise","planned":false,"acquired":false,"shares":6000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one (1) share of the Issuer's Common Stock upon settlement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The award vested or vests as to 1/4 of the total award annually beginning on March 15, 2025, subject to the reporting person's continued service to the Issuer through each vesting date."}],"balance_after":12000,"derivative":{"expiration_date":"2028-03-15","underlying":"Common Stock","underlying_shares":6000},"source":{"system":"sec-edgar","filing":"0001966716-26-000004","document":"form4-03172026_090341.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1623526/000196671626000004/form4-03172026_090341.xml","form_type":"4"}},{"id":837845,"issuer":{"id":1723,"kind":"organization","name":"Stoke Therapeutics, Inc.","symbol":"STOK"},"owners":[{"id":22216,"kind":"person","name":"Allan Jonathan","position":1,"cik":"0001966716","reported_name":"Allan Jonathan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"GENERAL COUNSEL & CORP SEC"}}],"security":"Restricted Stock Units","published_at":"2026-03-17T21:23:45.000Z","date":"2026-03-15","kind":"exercise","planned":false,"acquired":false,"shares":7475,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one (1) share of the Issuer's Common Stock upon settlement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The award vested or vests as to 1/4 of the total shares annually beginning March 15, 2024, subject to the reporting person's continued service to the Issuer through each vesting date."}],"balance_after":7475,"derivative":{"expiration_date":"2027-03-15","underlying":"Common Stock","underlying_shares":7475},"source":{"system":"sec-edgar","filing":"0001966716-26-000004","document":"form4-03172026_090341.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1623526/000196671626000004/form4-03172026_090341.xml","form_type":"4"}},{"id":837844,"issuer":{"id":1723,"kind":"organization","name":"Stoke Therapeutics, Inc.","symbol":"STOK"},"owners":[{"id":22216,"kind":"person","name":"Allan Jonathan","position":1,"cik":"0001966716","reported_name":"Allan Jonathan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"GENERAL COUNSEL & CORP SEC"}}],"security":"Common Stock","published_at":"2026-03-17T21:23:45.000Z","date":"2026-03-15","kind":"exercise","planned":false,"acquired":true,"shares":12000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":37731,"source":{"system":"sec-edgar","filing":"0001966716-26-000004","document":"form4-03172026_090341.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1623526/000196671626000004/form4-03172026_090341.xml","form_type":"4"}},{"id":837843,"issuer":{"id":1723,"kind":"organization","name":"Stoke Therapeutics, Inc.","symbol":"STOK"},"owners":[{"id":22216,"kind":"person","name":"Allan Jonathan","position":1,"cik":"0001966716","reported_name":"Allan Jonathan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"GENERAL COUNSEL & CORP SEC"}}],"security":"Common Stock","published_at":"2026-03-17T21:23:45.000Z","date":"2026-03-15","kind":"exercise","planned":false,"acquired":true,"shares":6000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":25731,"source":{"system":"sec-edgar","filing":"0001966716-26-000004","document":"form4-03172026_090341.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1623526/000196671626000004/form4-03172026_090341.xml","form_type":"4"}},{"id":837842,"issuer":{"id":1723,"kind":"organization","name":"Stoke Therapeutics, Inc.","symbol":"STOK"},"owners":[{"id":22216,"kind":"person","name":"Allan Jonathan","position":1,"cik":"0001966716","reported_name":"Allan Jonathan","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"GENERAL COUNSEL & CORP SEC"}}],"security":"Common Stock","published_at":"2026-03-17T21:23:45.000Z","date":"2026-03-15","kind":"exercise","planned":false,"acquired":true,"shares":7475,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"The reported total includes an aggregate 425 shares acquired pursuant to the Issuer's Employee Stock Purchase Plan in one or more transactions exempt pursuant to Rules 16b-3(c) and 16b-3(d)."}],"balance_after":19731,"source":{"system":"sec-edgar","filing":"0001966716-26-000004","document":"form4-03172026_090341.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1623526/000196671626000004/form4-03172026_090341.xml","form_type":"4"}},{"id":837957,"issuer":{"id":1723,"kind":"organization","name":"Stoke Therapeutics, Inc.","symbol":"STOK"},"owners":[{"id":40934,"kind":"person","name":"LEVIN ARTHUR A","position":1,"cik":"0001181556","reported_name":"LEVIN ARTHUR A","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-03-17T21:23:01.000Z","date":"2026-03-13","kind":"sale","planned":true,"acquired":false,"shares":605,"price":36.8,"value":22264.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction reported on this Form 4 was executed pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 12, 2025."}],"balance_after":4237,"source":{"system":"sec-edgar","filing":"0001181556-26-000005","document":"form4-03172026_090352.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1181556/000118155626000005/form4-03172026_090352.xml","form_type":"4"}},{"id":846078,"issuer":{"id":1723,"kind":"organization","name":"Stoke Therapeutics, Inc.","symbol":"STOK"},"owners":[{"id":29273,"kind":"person","name":"TZIANABOS ARTHUR","position":1,"cik":"0001586226","reported_name":"TZIANABOS ARTHUR","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Interim Executive Chair"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-03-12T20:57:26.000Z","date":"2026-03-10","kind":"exercise","planned":true,"acquired":false,"shares":3955,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Effective October 6, 2025, this option became fully vested and exercisable."}],"balance_after":118696,"derivative":{"exercise_price":8.33,"expiration_date":"2034-03-19","underlying":"Common Stock","underlying_shares":3955},"source":{"system":"sec-edgar","filing":"0001586226-26-000002","document":"form4-03122026_080323.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1623526/000158622626000002/form4-03122026_080323.xml","form_type":"4"}},{"id":846077,"issuer":{"id":1723,"kind":"organization","name":"Stoke Therapeutics, Inc.","symbol":"STOK"},"owners":[{"id":29273,"kind":"person","name":"TZIANABOS ARTHUR","position":1,"cik":"0001586226","reported_name":"TZIANABOS ARTHUR","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Interim Executive Chair"}}],"security":"Common Stock","published_at":"2026-03-12T20:57:26.000Z","date":"2026-03-10","kind":"sale","planned":true,"acquired":false,"shares":4355,"price":40.0033,"value":174214.3715,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction reported on this Form 4 was executed pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 15, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $40.00 to $40.095 per share, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":31339,"source":{"system":"sec-edgar","filing":"0001586226-26-000002","document":"form4-03122026_080323.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1623526/000158622626000002/form4-03122026_080323.xml","form_type":"4"}},{"id":846076,"issuer":{"id":1723,"kind":"organization","name":"Stoke Therapeutics, Inc.","symbol":"STOK"},"owners":[{"id":29273,"kind":"person","name":"TZIANABOS ARTHUR","position":1,"cik":"0001586226","reported_name":"TZIANABOS ARTHUR","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Interim Executive Chair"}}],"security":"Common Stock","published_at":"2026-03-12T20:57:26.000Z","date":"2026-03-10","kind":"exercise","planned":true,"acquired":true,"shares":3955,"price":8.33,"value":32945.15,"ownership":{"direct":true},"balance_after":35694,"source":{"system":"sec-edgar","filing":"0001586226-26-000002","document":"form4-03122026_080323.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1623526/000158622626000002/form4-03122026_080323.xml","form_type":"4"}},{"id":846289,"issuer":{"id":1723,"kind":"organization","name":"Stoke Therapeutics, Inc.","symbol":"STOK"},"owners":[{"id":40957,"kind":"person","name":"Krainer Adrian R.","position":1,"cik":"0001780081","reported_name":"Krainer Adrian R.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-03-12T20:56:06.000Z","date":"2026-03-10","kind":"sale","planned":true,"acquired":false,"shares":33243,"price":39.7366,"value":1320963.7938,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transaction reported on this Form 4 was executed pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 15, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $39.50 to $40.11 per share, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":283302,"source":{"system":"sec-edgar","filing":"0001780081-26-000004","document":"form4-03122026_080302.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1780081/000178008126000004/form4-03122026_080302.xml","form_type":"4"}}],"next_cursor":"2026-03-12T20:56:06.000000Z,846289"}